Akari Therapeutics (AKTX) Short Interest Ratio & Short Volume $1.38 -0.02 (-1.43%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$1.35 -0.03 (-2.17%) As of 05/2/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Akari Therapeutics Short Interest DataAkari Therapeutics (AKTX) has a short interest of 77,000 shares, representing 0.29% of the float (the number of shares available for trading by the public). This marks a 1.85% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 32,088 shares to cover all short positions.Current Short Interest77,000 sharesPrevious Short Interest75,600 sharesChange Vs. Previous Month+1.85%Dollar Volume Sold Short$92,307.60Short Interest Ratio2.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares26,593,000 sharesFloat Size26,490,000 sharesShort Percent of Float0.29%Today's Trading Volume8,068 sharesAverage Trading Volume32,088 sharesToday's Volume Vs. Average25% Short Selling Akari Therapeutics? Sign up to receive the latest short interest report for Akari Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAKTX Short Interest Over TimeAKTX Days to Cover Over TimeAKTX Percentage of Float Shorted Over Time Akari Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202577,000 shares $92,307.60 +1.9%0.3%2.5 $1.20 3/31/202575,600 shares $91,173.60 -11.7%0.6%2.7 $1.21 3/15/202585,600 shares $92,448.00 +10.7%0.7%2 $1.08 2/28/202577,300 shares $67,251.00 -0.5%0.6%1.7 $0.87 2/15/202577,700 shares $84,226.80 -38.7%0.6%1.4 $1.08 1/31/2025126,800 shares $138,212.00 -0.5%1.1%2.2 $1.09 1/15/2025127,400 shares $159,250.00 -11.7%1.1%2.3 $1.25 12/31/2024144,200 shares $175,924.00 +94.6%1.2%2.6 $1.22 12/15/202474,100 shares $72,099.30 +30.2%0.6%1.7 $0.97 11/30/202456,900 shares $68,849.00 +151.8%0.5%1.6 $1.21 Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/202422,600 shares $47,008.00 +6.1%0.2%0.7 $2.08 10/31/202421,300 shares $51,120.00 +15.1%0.2%1.3 $2.40 10/15/202418,500 shares $47,191.65 -52.7%0.2%1.1 $2.55 9/30/202439,100 shares $115,345.00 -3.9%0.3%2.1 $2.95 9/15/202440,700 shares $132,478.50 +4.4%0.3%2.4 $3.26 8/31/202439,000 shares $149,370.00 +33.6%0.3%1.8 $3.83 8/15/202429,200 shares $93,440.00 +17.7%0.2%1.2 $3.20 7/31/202424,800 shares $92,504.00 -0.4%0.3%1 $3.73 7/15/202424,900 shares $93,126.00 +236.5%0.3%1 $3.74 6/30/20247,400 shares $19,980.00 -53.2%0.1%0.3 $2.70 6/15/202415,800 shares $49,928.00 -26.9%0.2%0.6 $3.16 5/31/202421,600 shares $38,880.00 +71.4%0.3%0.9 $1.80 5/15/202412,600 shares $18,396.00 +472.7%0.2%0.7 $1.46 4/30/20242,200 shares $3,388.00 +266.7%0.0%0.1 $1.54 4/15/2024600 shares $720.00 -94.3%0.0%0.1 $1.20 3/31/202410,500 shares $19,582.50 +75.0%0.2%0.9 $1.87 3/15/20246,000 shares $11,820.00 -37.5%0.1%0.6 $1.97 2/29/20249,600 shares $21,216.00 +10.3%0.2%1.1 $2.21 2/15/20248,700 shares $20,706.00 +357.9%0.2%1 $2.38 1/31/20241,900 shares $4,807.00 -66.7%0.0%0.2 $2.53 1/15/20245,700 shares $16,416.00 +375.0%0.1%0.5 $2.88 12/31/20231,200 shares $3,744.00 -29.4%0.0%0.1 $3.12 12/15/20231,700 shares $4,760.00 -50.0%0.0%0.1 $2.80 11/30/20233,400 shares $10,030.00 -69.6%0.1%0.3 $2.95 11/15/202311,200 shares $35,504.00 -36.0%0.2%0.7 $3.17 10/31/202317,500 shares $61,425.00 +49.6%0.4%0.8 $3.51 10/15/202311,700 shares $42,705.00 -33.5%0.2%0.4 $3.65 9/30/202317,600 shares $69,520.00 +2.9%0.4%0.7 $3.95 9/15/202317,100 shares $62,244.00 +116.5%0.5%0.6 $3.64 8/31/20237,900 shares $24,885.00 -24.8%0.2%0.3 $3.15Gold Alert: The Truth About Fort Knox Is Coming (Ad)Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher. If you wait for the news to hit, you’ll already be too late.Click here now before the biggest gold run in decades kicks off. 8/15/202310,500 shares $39,585.00 -95.7%0.3%0.3 $3.77 7/31/2023243,800 shares $60,852.48 -29.2%N/A0.5 $0.25 7/15/2023344,200 shares $58,961.46 +67.3%N/A0.6 $0.17 6/30/2023205,700 shares $34,948.43 -1.5%N/A0.4 $0.17 6/15/2023208,800 shares $32,760.72 -3.7%N/A0.4 $0.16 5/31/2023216,700 shares $38,334.23 -5.2%N/A0.4 $0.18 5/15/2023228,600 shares $42,153.84 +104.5%N/A0.5 $0.18 4/30/2023111,800 shares $20,246.98 -62.3%N/A0.3 $0.18 4/15/2023296,900 shares $59,409.69 +128.0%N/A0.8 $0.20 3/31/2023130,200 shares $23,657.34 -21.5%N/A0.5 $0.18 3/15/2023165,800 shares $42,776.40 +79.4%N/A1.3 $0.26 2/28/202392,400 shares $31,878.00 +42.2%N/A0.8 $0.35 2/15/202365,000 shares $29,250.00 -30.6%N/A0.7 $0.45 1/31/202393,700 shares $43,739.16 -15.9%N/A1.2 $0.47 1/15/2023111,400 shares $60,111.44 +47.2%N/A1.4 $0.54 12/30/202275,700 shares $35,571.43 -2.1%N/A0.9 $0.47 12/15/202277,300 shares $35,558.00 -43.0%N/A1 $0.46 11/30/2022135,500 shares $74,877.30 -8.2%N/A1.3 $0.55 11/15/2022147,600 shares $84,279.60 +313.5%N/A1.5 $0.57 10/31/202235,700 shares $16,629.06 -44.8%N/A0.4 $0.47 10/15/202264,700 shares $31,470.08 -16.8%N/A0.7 $0.49 9/30/202277,800 shares $49,014.00 +215.0%0.5%0.8 $0.63 9/15/202224,700 shares $16,796.00 -10.5%0.2%0.3 $0.68 8/31/202227,600 shares $32,844.00 -47.1%0.2%0.4 $1.19 8/15/202252,200 shares $78,300.00 +1,435.3%0.4%0.7 $1.50 7/31/20223,400 shares $3,876.00 -95.0%0.0%0 $1.14 7/15/202267,300 shares $56,585.84 -10.7%0.5%1.1 $0.84 6/30/202275,400 shares $75,400.00 -30.1%0.5%1.4 $1.00 6/15/2022107,900 shares $104,663.00 -16.6%0.8%2 $0.97 5/31/2022129,300 shares $151,281.00 +35.8%N/A2.1 $1.17 5/15/202295,200 shares $104,720.00 +12.4%N/A1.5 $1.10 4/30/202284,700 shares $100,793.00 +4.6%N/A1.2 $1.19 4/15/202281,000 shares $97,200.00 -13.0%N/A1.1 $1.20 3/31/202293,100 shares $111,720.00 -12.3%N/A1.2 $1.20 3/15/2022106,200 shares $117,351.00 +14.9%N/A1 $1.11 2/28/202292,400 shares $124,740.00 -3.3%N/A0.9 $1.35 2/15/202295,500 shares $146,115.00 +24.8%N/A1 $1.53 1/31/202276,500 shares $104,805.00 -11.1%N/A0.8 $1.37 1/15/202286,000 shares $124,700.00 -40.5%N/A0.8 $1.45 12/31/2021144,500 shares $216,750.00 +113.4%N/A1.3 $1.50 12/15/202167,700 shares $101,570.31 +129.5%N/A0.7 $1.50 11/30/202129,500 shares $48,085.00 +87.9%N/A0.3 $1.63 11/15/202115,700 shares $25,905.00 -74.4%N/A0.1 $1.65 10/29/202161,300 shares $101,758.00 +48.8%N/A0.6 $1.66 10/15/202141,200 shares $67,980.00 -11.0%N/A0.4 $1.65 9/30/202146,300 shares $75,469.00 -38.8%N/A0.4 $1.63 9/15/202175,700 shares $139,288.00 +90.7%N/A0.7 $1.84 8/31/202139,700 shares $73,048.00 -2.0%N/A0.3 $1.84 8/13/202140,500 shares $67,635.00 -17.9%N/A0.3 $1.67 7/30/202149,300 shares $79,866.00 -40.8%N/A0.3 $1.62Gold Alert: The Truth About Fort Knox Is Coming (Ad)Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher. If you wait for the news to hit, you’ll already be too late.Click here now before the biggest gold run in decades kicks off. 7/15/202183,200 shares $137,280.00 +51.6%N/A0.2 $1.65 6/30/202154,900 shares $94,977.00 -43.6%N/A0.1 $1.73 6/15/202197,300 shares $170,275.00 +72.5%N/A0.2 $1.75 5/28/202156,400 shares $101,238.00 -39.6%N/A0.1 $1.80 5/14/202193,300 shares $167,940.00 -59.2%N/A0.2 $1.80 4/30/2021228,400 shares $477,356.00 +217.7%N/A0.5 $2.09 4/15/202171,900 shares $154,585.00 +276.4%N/A0.3 $2.15 3/31/202119,100 shares $48,514.00 -77.3%N/A0.1 $2.54 3/15/202184,200 shares $262,704.00 +231.5%N/A0.4 $3.12 2/26/202125,400 shares $84,328.00 -28.1%N/A0.1 $3.32 2/12/202135,300 shares $96,016.00 -77.7%N/A0.1 $2.72 1/29/2021158,000 shares $379,200.00 -16.8%N/A0.6 $2.40 1/15/2021189,800 shares $482,092.00 +10.3%N/A0.7 $2.54 12/31/2020172,100 shares $313,222.00 +10.8%N/A0.9 $1.82 12/15/2020155,300 shares $301,282.00 +119.0%N/A0.9 $1.94 11/30/202070,900 shares $111,313.00 +24.8%N/A0.5 $1.57 11/15/202056,800 shares $92,016.00 -15.0%N/A0.4 $1.62 10/30/202066,800 shares $106,212.00 -39.6%N/A0.5 $1.59 10/15/2020110,500 shares $202,215.00 -29.8%N/A0.6 $1.83 9/30/2020157,400 shares $273,876.00 -42.1%N/A0.8 $1.74 9/15/2020272,000 shares $465,120.00 +19.5%N/A1 $1.71 8/31/2020227,700 shares $391,644.00 +3.6%N/A0.7 $1.72 8/14/2020219,700 shares $417,430.00 +34.6%N/A0.6 $1.90 7/31/2020163,200 shares $328,032.00 +4.0%N/A0.4 $2.01 7/15/2020157,000 shares $312,430.00 +90.1%N/A0.4 $1.99 6/30/202082,600 shares $186,676.00 -56.7%N/A0.2 $2.26 6/15/2020190,900 shares $376,073.00 +186.2%N/A0.7 $1.97 5/29/202066,700 shares $133,400.00 -35.8%N/A0.3 $2.00 5/15/2020103,900 shares $180,786.00 -11.1%N/A0.6 $1.74 AKTX Short Interest - Frequently Asked Questions What is Akari Therapeutics' current short interest? Short interest is the volume of Akari Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 77,000 shares of AKTX short. 0.29% of Akari Therapeutics' shares are currently sold short. Learn More on Akari Therapeutics' current short interest. What is a good short interest ratio for Akari Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKTX shares currently have a short interest ratio of 2.0. Learn More on Akari Therapeutics's short interest ratio. What is a good short interest percentage for Akari Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.29% of Akari Therapeutics' floating shares are currently sold short. Is Akari Therapeutics' short interest increasing or decreasing? Akari Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 77,000 shares, an increase of 1.9% from the previous total of 75,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Akari Therapeutics' float size? Akari Therapeutics currently has issued a total of 26,593,000 shares. Some of Akari Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Akari Therapeutics currently has a public float of 26,490,000 shares. How does Akari Therapeutics' short interest compare to its competitors? 0.29% of Akari Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Akari Therapeutics: Tiziana Life Sciences Ltd (1.46%), Nkarta, Inc. (11.18%), Lyell Immunopharma, Inc. (4.52%), scPharmaceuticals Inc. (10.66%), Larimar Therapeutics, Inc. (9.14%), Contineum Therapeutics, Inc. (5.10%), Korro Bio, Inc. (18.16%), Organigram Holdings Inc. (6.63%), Eupraxia Pharmaceuticals Inc. (0.52%), Compugen Ltd. (2.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Akari Therapeutics stock? Short selling AKTX is an investing strategy that aims to generate trading profit from Akari Therapeutics as its price is falling. AKTX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Akari Therapeutics? A short squeeze for Akari Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AKTX, which in turn drives the price of the stock up even further. How often is Akari Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKTX, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies TLSA Short Interest NKTX Short Interest LYEL Short Interest SCPH Short Interest LRMR Short Interest CTNM Short Interest KRRO Short Interest OGI Short Interest EPRX Short Interest CGEN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AKTX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AKTX Stock Free AKTX Stock Alerts